pyridoxine has been researched along with Dysmyelopoietic Syndromes in 9 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
| Excerpt | Relevance | Reference |
|---|---|---|
| "VB6 deficiency anemia is typically microcytic, hypochromic, and sideroblastic." | 5.72 | Vitamin B6 Deficiency Anemia Attributed to Levodopa/Carbidopa Intestinal Gel Therapy for Parkinson's Disease: A Diagnostic Pitfall for Myelodysplastic Syndrome with Ring Sideroblasts. ( Ando, M; Hatano, T; Hattori, N; Honda, T; Komatsu, N; Tsutsui, M; Yasuda, H, 2022) |
| "The case history of two sisters with pyridoxine-refractory familial sideroblastic anemia (FSA) is presented in which one developed a myelodysplastic syndrome (MDS) with monosomy for chromosome 5." | 3.69 | Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome. ( de Waal, FC; Kardos, G; Slater, R; van Oudheusden, LJ; Veerman, AJ, 1996) |
| "The treatment of myelodysplastic syndromes is reviewed, with emphasis on recently published clinical trials." | 2.37 | Management of myelodysplastic syndromes. ( Buzaid, AC; Garewal, HS; Greenberg, BR, 1986) |
| "VB6 deficiency anemia is typically microcytic, hypochromic, and sideroblastic." | 1.72 | Vitamin B6 Deficiency Anemia Attributed to Levodopa/Carbidopa Intestinal Gel Therapy for Parkinson's Disease: A Diagnostic Pitfall for Myelodysplastic Syndrome with Ring Sideroblasts. ( Ando, M; Hatano, T; Hattori, N; Honda, T; Komatsu, N; Tsutsui, M; Yasuda, H, 2022) |
| "A case of acquired haemophilia A presenting with extensive spontaneous bruising and anaemia is reported." | 1.28 | Myelodysplastic syndrome and acquired factor VIII inhibitor with severe subcutaneous haemorrhage. ( Chan, GT; Liang, R; Lin, CK; Liu, HW; Tse, PW, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, H | 1 |
| Hatano, T | 1 |
| Honda, T | 1 |
| Tsutsui, M | 1 |
| Hattori, N | 1 |
| Ando, M | 1 |
| Komatsu, N | 1 |
| Kim, CK | 1 |
| Han, DH | 1 |
| Ji, YS | 1 |
| Lee, MS | 1 |
| Min, CW | 1 |
| Park, SK | 1 |
| Kim, SH | 1 |
| Yun, J | 1 |
| Kim, HJ | 1 |
| Kim, KH | 1 |
| Lee, KT | 1 |
| Won, JH | 1 |
| Hong, DS | 1 |
| Kim, HK | 1 |
| Irwin, J | 1 |
| D'Souza, A | 1 |
| Johnson, L | 1 |
| Carter, J | 1 |
| Kardos, G | 1 |
| Veerman, AJ | 1 |
| de Waal, FC | 1 |
| van Oudheusden, LJ | 1 |
| Slater, R | 1 |
| Lengfelder, E | 1 |
| Hehlmann, R | 1 |
| Wang, XT | 1 |
| He, HT | 1 |
| Lin, CK | 1 |
| Liang, R | 1 |
| Liu, HW | 1 |
| Tse, PW | 1 |
| Chan, GT | 1 |
| Buzaid, AC | 1 |
| Garewal, HS | 1 |
| Greenberg, BR | 1 |
| Takaku, F | 1 |
1 review available for pyridoxine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Management of myelodysplastic syndromes.
Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; | 1986 |
8 other studies available for pyridoxine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Vitamin B6 Deficiency Anemia Attributed to Levodopa/Carbidopa Intestinal Gel Therapy for Parkinson's Disease: A Diagnostic Pitfall for Myelodysplastic Syndrome with Ring Sideroblasts.
Topics: Aged; Anemia; Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Male; Myel | 2022 |
Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow Examination; Humans; Immunosuppressive Agent | 2016 |
Myelodysplasia in the Wellington region 2002-2007: disease incidence and treatment patterns.
Topics: Aged; Aged, 80 and over; Bone Marrow Examination; Erythrocyte Transfusion; Ethnicity; Female; Ferrit | 2011 |
Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome.
Topics: Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Child; Chromosomes, Human, Pair 5; | 1996 |
[Treatment of myelodysplastic syndromes aside from clinical studies].
Topics: Age Factors; Aged; Danazol; Erythrocyte Transfusion; Estrogen Antagonists; Female; Humans; Myelodysp | 1995 |
[Treatment of myelodysplastic syndrome by combined traditional Chinese medicine and Western medicine therapy].
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Cytarabine; Drugs, Chinese Herbal; Female; | 1993 |
Myelodysplastic syndrome and acquired factor VIII inhibitor with severe subcutaneous haemorrhage.
Topics: Aged; Anemia, Sideroblastic; Bone Marrow; Factor VIII; Female; Hemophilia A; Hemorrhage; Humans; Mye | 1991 |
[myelodysplastic syndrome].
Topics: Aged; Bone Marrow Cells; Hematopoiesis; Humans; Middle Aged; Myelodysplastic Syndromes; Prognosis; P | 1985 |